"Head and Neck Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
| Descriptor ID |
D006258
|
| MeSH Number(s) |
C04.588.443
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Head and Neck Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Head and Neck Neoplasms".
This graph shows the total number of publications written about "Head and Neck Neoplasms" by people in this website by year, and whether "Head and Neck Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 7 | 1 | 8 |
| 1996 | 7 | 1 | 8 |
| 1997 | 3 | 1 | 4 |
| 1998 | 6 | 0 | 6 |
| 1999 | 13 | 1 | 14 |
| 2000 | 14 | 1 | 15 |
| 2001 | 8 | 3 | 11 |
| 2002 | 8 | 0 | 8 |
| 2003 | 12 | 1 | 13 |
| 2004 | 16 | 1 | 17 |
| 2005 | 13 | 1 | 14 |
| 2006 | 14 | 1 | 15 |
| 2007 | 15 | 2 | 17 |
| 2008 | 17 | 2 | 19 |
| 2009 | 19 | 1 | 20 |
| 2010 | 15 | 4 | 19 |
| 2011 | 15 | 1 | 16 |
| 2012 | 14 | 1 | 15 |
| 2013 | 12 | 2 | 14 |
| 2014 | 32 | 3 | 35 |
| 2015 | 23 | 2 | 25 |
| 2016 | 27 | 3 | 30 |
| 2017 | 22 | 1 | 23 |
| 2018 | 18 | 4 | 22 |
| 2019 | 22 | 2 | 24 |
| 2020 | 19 | 0 | 19 |
| 2021 | 22 | 1 | 23 |
| 2022 | 19 | 0 | 19 |
| 2023 | 18 | 1 | 19 |
| 2024 | 5 | 2 | 7 |
| 2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Head and Neck Neoplasms" by people in Profiles.
-
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 01; 11(5):492-501.
-
Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers. Neoplasia. 2025 May; 63:101157.
-
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas. Oral Oncol. 2025 Apr; 163:107207.
-
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025. J Natl Compr Canc Netw. 2025 02; 23(2):2-11.
-
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study. J Immunother Cancer. 2024 Nov 03; 12(11).
-
Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma. J Transl Med. 2024 Oct 22; 22(1):960.
-
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Oct; 8:e2400477.
-
Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab. Cancer Gene Ther. 2024 Oct; 31(10):1477-1485.
-
Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e433330.
-
Air pollution is associated with increased incidence-rate of head and neck cancers: A nationally representative ecological study. Oral Oncol. 2024 Mar; 150:106691.